Pathogenesis of Skin Carcinomas and a Stem Cell as Focal Origin

por de Gruijl, Frank R., Tensen, Cornelis P.
Publicado 2018

Sun Exposure Public Health Directives

por Hoel, David G., de Gruijl, Frank R.
Publicado 2018

From simplicity to complexity in current melanoma models

por Michielon, Elisabetta, de Gruijl, Tanja D., Gibbs, Susan
Publicado 2022

A shift from papillary to reticular fibroblasts enables tumour–stroma interaction and invasion

por Hogervorst, Marieke, Rietveld, Marion, de Gruijl, Frank, El Ghalbzouri, Abdoelwaheb
Publicado 2018

The risks and benefits of sun exposure 2016

por Hoel, David G., Berwick, Marianne, de Gruijl, Frank R., Holick, Michael F.
Publicado 2016

Risk assessment for the harmful effects of UVB radiation on the immunological resistance to infectious diseases.

por Goettsch, W, Garssen, J, Slob, W, de Gruijl, F R, Van Loveren, H
Publicado 1998

UV-B exposure impairs resistance to infection by Trichinella spiralis.

por Goettsch, W, Garssen, J, Deijns, A, de Gruijl, F R, van Loveren, H
Publicado 1994

Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression

por van de Ven, Rieneke, Lindenberg, Jelle J., Oosterhoff, Dinja, de Gruijl, Tanja D.
Publicado 2013

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node mi...

por Rotman, J., Mom, C. H., Jordanova, E. S., de Gruijl, T. D., Kenter, G. G.
Publicado 2018

Climbing Fiber Burst Size and Olivary Sub-threshold Oscillations in a Network Setting

por De Gruijl, Jornt R., Bazzigaluppi, Paolo, de Jeu, Marcel T. G., De Zeeuw, Chris I.
Publicado 2012

Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing

por van de Glind, Gerline, Rebel, Heggert, van Kempen, Marika, Tensen, Kees, de Gruijl, Frank
Publicado 2016

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2018

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2018

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

por Rotman, Jossie, Koster, Bas D., Jordanova, Ekaterina S., Heeren, A. Marijne, de Gruijl, Tanja D.
Publicado 2019

Proteasome inhibitors as experimental therapeutics of autoimmune diseases

por Verbrugge, Sue Ellen, Scheper, Rik J, Lems, Willem F, de Gruijl, Tanja D, Jansen, Gerrit
Publicado 2015

Gingiva Equivalents Secrete Negligible Amounts of Key Chemokines Involved in Langerhans Cell Migration Compared to Skin Equivalents

por Kosten, Ilona J., Buskermolen, Jeroen K., Spiekstra, Sander W., de Gruijl, Tanja D., Gibbs, Susan
Publicado 2015

Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin

por Kosten, Ilona Jennifer, van de Ven, Rieneke, Thon, Maria, Gibbs, Susan, de Gruijl, Tanja D.
Publicado 2017

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy

por van Pul, Kim M., Fransen, Marieke F., van de Ven, Rieneke, de Gruijl, Tanja D.
Publicado 2021

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma

por van Vliet, Amanda A., Georgoudaki, Anna-Maria, Raimo, Monica, de Gruijl, Tanja D., Spanholtz, Jan
Publicado 2021

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

por de Gruijl, Tanja D., van den Eertwegh, Alfons J. M., Pinedo, Herbert M., Scheper, Rik J.
Publicado 2008